However, the declining trend in CD4 + count testing has been observed across sub-Saharan Africa, posing a risk of overlooking AHD diagnoses and potentially jeopardizing the effectiveness of antiretroviral therapy (ART) programs [27]. Here, CD4 is linked to mitochondrial DNA depletion syndrome 4a.